Asterias Biotherapeutics Inc
(AST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,568 | 11,183 | 12,645 | 15,636 | 7,421 |
| Marketable Securities | 11,949 | 17,006 | 11,561 | 13,990 | 19,153 |
| Receivables | N/A | 567 | 1,525 | 2,771 | 277 |
| TOTAL | $20,674 | $29,789 | $26,561 | $33,024 | $27,361 |
| Non-Current Assets | |||||
| PPE Net | 5,539 | 5,756 | 843 | 940 | 928 |
| Investments And Advances | 0 | 416 | 416 | 416 | 416 |
| Intangibles | 20,145 | 20,816 | 21,488 | 22,159 | 22,831 |
| Other Non-Current Assets | 8,292 | 457 | 5,063 | 3,777 | 968 |
| TOTAL | $33,976 | $27,445 | $27,810 | $27,292 | $25,142 |
| Total Assets | $54,650 | $57,234 | $54,371 | $60,316 | $52,503 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,906 | 747 | 399 | 1,389 | 1,132 |
| Accrued Expenses | 1,152 | 1,183 | 1,631 | 580 | 590 |
| Other current liabilities | 833 | 530 | 264 | 166 | 863 |
| TOTAL | $10,115 | $4,980 | $7,892 | $8,590 | $10,445 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,270 | 2,513 | 1,869 | 1,877 | 1,474 |
| Other Non-Current Liabilities | 4,300 | 4,400 | 4,089 | 3,331 | 561 |
| TOTAL | $11,204 | $7,155 | $4,311 | $5,057 | $3,526 |
| Total Liabilities | $21,319 | $12,135 | $12,203 | $13,647 | $13,971 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,554 | 38,352 | 37,642 | 37,602 | 32,322 |
| Common Shares | 4 | 4 | 4 | 4 | 3 |
| Retained earnings | -58,576 | -48,239 | -43,334 | -39,826 | -36,208 |
| Other shareholders' equity | -4,399 | 434 | -2,331 | -752 | 2,603 |
| TOTAL | $33,331 | $45,099 | $42,168 | $46,669 | $38,532 |
| Total Liabilities And Equity | $54,650 | $57,234 | $54,371 | $60,316 | $52,503 |